Submitted: 03 May 2019
Accepted: 04 Jun 2019
First published online: 19 Jun 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

J Renal Inj Prev. 2019;8(3):169-171.
doi: 10.15171/jrip.2019.31
  Abstract View: 277
  PDF Download: 221

Editorial

Acetazolamide therapy for hypokalemic alkalosis in Bartter syndrome

Farahnak Assadi * ORCiD

1 Department of Pediatrics, Division of Nephrology, Rush University Medical Center, 445 E. North Water Street, Suite 1804, Chicago, Illinois, USA
Department of Pediatrics, Division of Nephrology, Rush University Medical Center, 445 E. North Water Street, Suite 1804, Chicago, Illinois, USA Email:

Implication for health policy/practice/research/medical education:

There is no information available on the efficacy of acetazolamide on the management of severe hypokalemic alkalosis refractory to the standard therapy. A benefit from acetazolamide appears to be apparent in the management of hypokalemic alkalosis in patients with Barter syndrome.

Please cite this paper as: Assadi F. Acetazolamide therapy for hypokalemic alkalosis in Bartter syndrome. J Renal Inj Prev. 2019; 8(3): 169-171. DOI: 10.15171/jrip.2019.31.

First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 277

Your browser does not support the canvas element.


PDF Downloaded: 221

Your browser does not support the canvas element.